Deans' stroke musings: Virtual reality glove for home-based hand and arm stroke rehabilitation (vREHAB)

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, September 19, 2025

Virtual reality glove for home-based hand and arm stroke rehabilitation (vREHAB)

Let's see how long your doctor has been incompetent in not bringing in recovery interventions. I'm sure your doctor has a much lower definition of competence. Which definition do stroke survivors prefer?

South Korean Tech Company Neofect Creates 'Raphael Smart Glove,' Designed To Help Stroke Victims Regain Arm And Hand Skills November 2015

NEOFECT Has Partnered with the U.S. Department of Veterans Affairs and the Rehabilitation Institute of Chicago to Bring Technological Innovations to Stroke Survivors - Rapael Smart Glove December 2016

Virtual reality glove for home-based hand and arm stroke rehabilitation (vREHAB)

Affiliations

PMID: 40948414
DOI: 10.1002/pmrj.70014

Abstract

Background: Upper extremity impairment is common after stroke. Virtual-reality rehabilitation systems may help restore hand and arm function.

Objective: To assess the feasibility of the Neofect Smart Glove and its effect on functional recovery.

Design: Multicenter, prospective, randomized, open-label, blinded-endpoint phase 2 trial consisting of a 12-week active treatment period followed by a 12-week follow-up period.

Study population: Patients with subacute and chronic stroke with upper extremity impairment.

Interventions: Patients assigned to the intervention group were instructed to use the Smart Glove for a minimum of one session per day for at least 5 days per week during the 12-week active treatment period, in addition to their usual care. Patients in the control group received their usual care only.

Outcomes: Feasibility was assessed by the total dose of rehabilitation. The change from baseline to week 12 on the Jebsen-Taylor Hand Function Test (JTHFT) was the primary efficacy outcome and the change on the Upper Extremity Fugl-Meyer Assessment (UE-FMA) was secondary.

Statistics: Differences between treatment arms were compared using analysis of covariance in the overall population and, separately, in a post-hoc and exploratory analysis consisting of a subset of patients with mild to moderate upper extremity impairment (baseline JTHFT ≤500).

Results: During the 12-week active treatment period, there were no differences between the intervention (n = 18) and control (n = 24) groups in the change in the JTHFT (median -64 vs. -69 seconds, p = .88), the change in the UE-FMA (median 8 vs. 8 points, p = .61), or the total dose of rehabilitation (median 1434 vs. 584 minutes, p = .18). Among the subgroup of patients with mild to moderate symptoms (baseline JTHFT ≤500, n = 31), Smart Glove assignment was associated with a greater improvement on the JTHFT (median -72 vs. -40 seconds, p = .01) and a greater dose of rehabilitation (median 1739 vs. 510 minutes, p = .04) during the active treatment period, but there was no difference in the change in the UE-FMA (median 10 vs. 8 points, p = .15).

Conclusion: The addition of the Smart Glove to traditional rehabilitation therapy did not improve hand and arm function in the overall study population but may increase the dose of rehabilitation and improve hand and arm function for patients with mild to moderate upper extremity impairment.